Patient Guide: A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 123 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06667076
Status: 🟢 Enrolling Now
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE2

Where You Can Participate

This study is available at 123 locations across the country.

Top locations include:
  • • Daphne, Alabama
  • • Huntsville, Alabama
  • • Goodyear, Arizona
  • • And 120 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) - Join Clinical Trial NCTNCT06667076

How to Join This Clinical Trial - NCTNCT06667076

Learn how to participate in this PHASE2 trial studying an investigational therapy for Carcinoma, Non-Small-Cell Lung. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06667076 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 123 locations. Find a study site near you:

Clinical Research Site

Daphne, Alabama 36526 - United States

Status: RECRUITING

Clinical Research Site

Huntsville, Alabama 35805 - United States

Status: RECRUITING

Clinical Research Site

Goodyear, Arizona 85338 - United States

Status: RECRUITING

Clinical Research Site

Corona, California 92882 - United States

Status: RECRUITING

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Fullerton, California 92835 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 90015 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91203 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91204 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91206 - United States

Status: RECRUITING

And 113 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships